Melatonin reduces lipid and protein oxidative damage in synaptosomes due to aluminium

被引:34
作者
Albendea, Carlos David [1 ]
Gomez-Trullen, Eva Maria [1 ]
Fuentes-Broto, Lorena [1 ]
Miana-Mena, Francisco Javier [1 ]
Millan-Plano, Sergio [1 ]
Reyes-Gonzales, Marcos Cesar [1 ]
Martinez-Ballarin, Enrique [1 ]
Garcia, Joaquin J. [1 ]
机构
[1] Univ Zaragoza, Dept Pharmacol & Physiol, E-50009 Zaragoza, Spain
关键词
melatonin; aluminium; iron; lipid oxidation; protein oxidation;
D O I
10.1016/j.jtemb.2007.04.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Prolonged exposure to excessive aluminium (Al) concentrations is involved in the ethiopathology of certain dementias and neurological disorders. Melatonin is a well-known antioxidant that efficiently reduces lipid peroxidation due to oxidative stress. Herein, we investigated in synaptosomal membranes the effect of melatonin in preventing Al promotion of lipid and protein oxidation when the metal was combined with FeCl3 and ascorbic acid. Lipid peroxidation was estimated by quantifying malondialdehyde (MDA) and 4-hydroxyalkenals (4-HDA) concentrations in the membrane suspension and protein carbonyls were measured in the synaptosomes as an index of oxidative damage. Under our experimental conditions, the addition of A] (0.0001-1mmol/L) enhanced MDA+4-HDA formation in the synaptosomes. In addition, Al (1 mmol/L) raised protein carbonyl contents. Melatonin reduced, in a concentration-dependent manner, lipid and protein oxidation due to Al, FeCl3 and ascorbic acid in the synaptosomal membranes. These results show that melatonin confers protection against Al-induced oxidative damage in synaptosomes and suggest that this indoleamine may be considered as a neuroprotective agent in Al toxicity because of its antioxidant activity. (c) 2007 Elsevier GmbH. All rights reserved.
引用
收藏
页码:261 / 268
页数:8
相关论文
共 59 条
[1]
Abd-Elghaffar SK, 2005, NEUROENDOCRINOL LETT, V26, P609
[2]
DIALYSIS ENCEPHALOPATHY SYNDROME - POSSIBLE ALUMINUM INTOXICATION [J].
ALFREY, AC ;
LEGENDRE, GR ;
KAEHNY, WD .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (04) :184-188
[3]
BEARD JL, 1993, NUTR REV, V51, P157, DOI 10.1111/j.1753-4887.1993.tb03096.x
[4]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]
Melatonin reduces oxidative neurotoxicity due to quinolinic acid: In vitro and in vivo findings [J].
Cabrera, J ;
Reiter, RJ ;
Tan, DX ;
Qi, WB ;
Sainz, RM ;
Mayo, JC ;
Garcia, JJ ;
Kim, SJ ;
El-Sokkary, G .
NEUROPHARMACOLOGY, 2000, 39 (03) :507-514
[6]
Evidence for melatonin synthesis in mouse and human bone marrow cells [J].
Conti, A ;
Conconi, S ;
Hertens, E ;
Skwarlo-Sonta, K ;
Markowska, M ;
Maestroni, GJM .
JOURNAL OF PINEAL RESEARCH, 2000, 28 (04) :193-202
[7]
Permeability of pure lipid bilayers to melatonin [J].
Costa, EJX ;
Lopes, RH ;
LamyFreund, MT .
JOURNAL OF PINEAL RESEARCH, 1995, 19 (03) :123-126
[8]
Singlet oxygen-mediated damage to proteins and its consequences [J].
Davies, MJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 305 (03) :761-770
[9]
NEUROTOXIC CATIONS INDUCE MEMBRANE RIGIDIFICATION AND MEMBRANE-FUSION AT MICROMOLAR CONCENTRATIONS [J].
DELEERS, M ;
SERVAIS, JP ;
WULFERT, E .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 855 (02) :271-276
[10]
MICROMOLAR CONCENTRATIONS OF AL-3+ INDUCE PHASE-SEPARATION, AGGREGATION AND DYE RELEASE IN PHOSPHATIDYLSERINE-CONTAINING LIPID VESICLES [J].
DELEERS, M ;
SERVAIS, JP ;
WULFERT, E .
BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 813 (02) :195-200